The chemistry and biological effects of flavonoids and phenolic acids

Annals of the New York Academy of Sciences

Volumn 854, Issue , 1998, Pages 435-442

  Croft, Kevin D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FLAVONOID; PHENOL DERIVATIVE;

ABSORPTION; ANTIOXIDANT ACTIVITY; BEVERAGE; BIOAVAILABILITY; BIOLOGY; BIOSYNTHESIS; CHEMISTRY; CONFERENCE PAPER; DIETARY INTAKE; HEALTH; HIGHER PLANT; HUMAN; METABOLISM; STRUCTURE ACTIVITY RELATION; WINE;

EMBRYOPHYTA;

EID: 0032441095     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09922.x     Document Type: Conference Paper

References (41)

1. BLOCK, G. & L. LANGSETH. 1994. Antioxidant vitamins and disease prevention. Food Technol. July: 80-84.
2. BLOCK, G. 1992. A role for antioxidants in reducing cancer risk. Nutr. Rev. 50: 207-213.
3. HERTOG, M.G.L., E.J.M. FESKENS, P.C.H. HOLLMAN, M.B. KATAN, & D. KROMHOUT. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet 342: 1007-1011.
4. HALLIWELL, B. 1994. Free radicals, antioxidants and human disease: Curiosity, cause or consequence? Lancet 344: 721-724.
5. RICE-EVANS, C.A., N.J. MILLER & G. PAGANGA. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol. Med. 20: 9.
6. COOK, N.C. & S. SAMMAN. 1996. Flavonoids, chemistry, metabolism, cardioprotective effects and dietary sources. J. Nutr. Biochem. 7: 66-76.
7. BORS, W., W. HELLER, C. MICHEL & M. SARAN. 1990. Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol. 186: 343-355.
8. MANN, J. 1978. Secondary Metabolism. Oxford Chemistry Series. Clarendon Press. Oxford.
9. STAGG, G.V. & D.J. MILLIN. 1975. The nutritional and therapeutic value of tea - a review. J. Sci. Food Agric. 26: 1439-1459.
10. FRANKEL, E.N., A.L. WATERHOUSE & P.L. TEISSEDRE. 1995. Principle phenolic phytochemicals in selected Californian wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J. Agric. Food Chem. 43: 890-894.
11. HALLIWELL, B., R. AESCHBACH, J. LOLIGER & O.I. ARUOMA. 1995. The characterization of antixoidants. Food Chem. Toxicol. 33: 601-617.
12. SHAHIDI, F. & P.K.J.P.D. WANASUNDARA. 1992. Phenolic Antioxidants. Crit. Rev. Food Sci. Nutr. 32: 67-103.
13. CAO, G., E. SOFIC & R.L. PRIOR. 1997. Antioxidant and pro-oxidant behaviour of flavonoids: Structure-activity relationships. Free Radical Biol. Med. 22: 749-760.
14. VAN ACKER, S.A.B.E., D.J. VAND DEN BERG, M.N.J.L. TROMP, D.H. GRIFTIOEN, W.P. VAN BENNEKOM, W.J.F. VAN DER VIJGH & A. BAST. 1996. Structural aspects of antioxidant activity of flavonoids. Free Radical Biol. Med. 20: 331-342.
15. CHEN, Z.Y., P.T. CHAN, K.Y. HO, K.P. FUNG & J. WANG. 1996. Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups. Chem. Phys. Lipids 76: 157-163.
16. LARANJINHA, J.A.N., L.M. ALMEIDA & V.M.C. MADEIRA. 1994. Reactivity of dietary phenolic acids with peroxyl radicals: Antioxidant activity upon low density lipoprotein peroxidation Biochem. Pharmacol. 48: 487-494.
17. NARDINI, M., M. D'AQUINO, G. TOMASSI, V. GENTILI, N. DI FELICE & C. SCACCINI. 1995. Inhibition of human LDL oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radical Biol. Med. 19: 541-552.
18. ABU-AMSHA, R., K.D. CROFT, I.E. PUDDEY, J.M. PROUDFOOT & L.J. BEILIN. 1996. Phenolic content of various beverages determines the extent of inhibition of human serum and low density lipoprotein oxidation in vitro: Identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin. Sci. 91: 449-458.
19. THMAS, S.R., P.K. WITTING & R. STOCKER. 1996. 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for α-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. J. Biol. Chem. 271: 32714-32721.
20. KANDASWAMI, G., E. PERKINS, D.S. SOLONIUK, G. DRZEWIECKI & E. MIDDLETON. 1993. Ascorbic acid enhanced antiproliferative effect of flavonoids on squamous cell carcinoma in vitro. Anticancer Drugs 4: 91-96.
21. 2+-induced low density lipoprotein oxidation. FEBS Lett. 405: 186-190.
22. HALLTWELL, B. & J.M.C. GUTTERRIDCE. 1990. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280: 1-8.
23. HALLIWELL, B., J.M.C. GUTTERIDGE & C.E. CROSS. 1992. Free radicals, antioxidants and human disease: Where are we now? J. Lab. Clin. Med. 119: 598-620.
24. SMITH, C, M.J. MITCHLNSON, O.I. ARUDMA & B. HALLIWELL. 1992. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286: 901-905.
25. HOLLMAN, P.C.H. 1997. Bioavailability of flavonoids. Eur. J. Clin. Nutr. 51: S66-S69.
26. HOLLMAN, P.C.H. et al. 1995. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62: 1276-1282.
27. COVA, D. et al. 1992. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 30: 279-286.
28. HACKETT, A.M. 1983. The metabolism and excretion of (+)- 14C-cyanidenol-3 in man following oral administration. Xenobiotica 13: 279-286.
29. GRIFFITHS, L. 1982. Mammalian metabolism of flavonoids. In: The Flavonoids: Advances in Research. J. Harborne & T. Mabry, Eds.: 681-718. Chapman and Hall. London.
30. PAGANGA, G. & C.A. RICE-EVANS. 1997. The identification of flavonoids as glycosides in human plasma. FEBS Lett. 401: 78-82.
31. LEE, M.J. et al. 1995. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4: 393-399.
32. ADLERCREUTZ, H., H. MARKKANEN & S. WATANABE. 1993. Plasma concentrations of phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 342: 1209-1210.
33. XU, X. et al. 1994. Daiadzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124: 825-832.
34. HALLIWELL, B. 1996. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxident intake in humans. Free Radical Res. 25: 57-74.
35. MORROW, J.D. & L.J. ROBERTS. 1996. The isoprostanes: Current knowledge and directions for future research. Biochem. Pharmacol. 51: 1-9.
36. WANG, Z. et al. 1995. Immunological characterization of urinary 8-epi-prostaglandin F2α excretion in man. J. Pharmacol. Exp. Ther. 275: 94-100.
37. Puddey, I.E. & K.D. Croft. 1997. Alcoholic beverages and lipid peroxidation: Relevance to cardiovascular disease. Addiction Biol. 2: 269-276.
38. FRANKEL, E.N., J. KANNER, J.B. GERMAN, E. PARKS & J.E. KINSELLA. 1993. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 341: 454-457.
39. FUHRMAN, B., A. LAVY & M. AVIRAM. 1995. Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 61: 549-554.
40. SHARPE, P.C., L.T. MCGRATH, E. MCLEAN, I.S. YOUND & G.P. ARCHIBOLD. 1995. Effect of red wine consumption on lipoprotein (a) and other risk factors for atherosclerosis. Q. J. Med. 88: 101-108.
41. DE RIJKE, X.B., P.N.M. DEMACKER, N.A. ASSEN et al. 1996. Red wine consumption does not effect oxidizability of low density lipoproteins in volunteers. Am. J. Clin. Nutr. 63: 329-334.